Burden of hospitalizations related to adverse drug events in the USA: a retrospective analysis from large inpatient database

Adverse drug events (ADEs) represent medication‐related patient harm, which is associated with significant patient morbidity and mortality. This study was conducted to determine the rate, specific causes, and outcomes of ADE‐related hospitalization in the USA.

[1]  N. Laird,et al.  Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention , 1995 .

[2]  K Henriksen,et al.  Using ICD-9-CM Codes in Hospital Claims Data to Detect Adverse Events in Patient Safety Surveillance -- Advances in Patient Safety: New Directions and Alternative Approaches (Vol. 1: Assessment) , 2008 .

[3]  Wu Xu,et al.  Performance of International Classification of Diseases, 9th Revision, Clinical Modification Codes as an Adverse Drug Event Surveillance System , 2006, Medical care.

[4]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[5]  Max Petzold,et al.  Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions – A Meta-Analysis , 2012, PloS one.

[6]  D. Bates,et al.  Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. , 1997, Critical care medicine.

[7]  Emily R. Hajjar,et al.  Polypharmacy in elderly patients. , 2007, The American journal of geriatric pharmacotherapy.

[8]  International drug monitoring: the role of national centres. Report of a WHO meeting. , 1972, World Health Organization technical report series.

[9]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[10]  Wu Xu,et al.  Using ICD-9-CM Codes in Hospital Claims Data to Detect Adverse Events in Patient Safety Surveillance , 2008 .

[11]  Tom Fahey,et al.  Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study , 2015, BMJ Open.

[12]  J Mainz,et al.  How are medication errors defined? A systematic literature review of definitions and characteristics. , 2010, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[13]  Cordula Wagner,et al.  Potentially inappropriate medication use among elderly home care patients in Europe. , 2005, JAMA.

[14]  J. Stephens,et al.  Published costs of Medication errors leading to preventable adverse Drug events in US Hospitals , 2015 .

[15]  A. Elixhauser,et al.  Characteristics of Adverse Drug Events Originating During the Hospital Stay, 2011 , 2013 .

[16]  R. Jiménez-García,et al.  Trends of adverse drug reactions related-hospitalizations in Spain (2001-2006) , 2010, BMC health services research.

[17]  D. Bates,et al.  Global priorities for patient safety research , 2009, BMJ : British Medical Journal.

[18]  Azeem Majeed,et al.  Ten-year trends in hospital admissions for adverse drug reactions in England 1999–2009 , 2010, Journal of the Royal Society of Medicine.

[19]  J. Rivera,et al.  Prevalence of Polypharmacy, Polyherbacy, Nutritional Supplement Use and Potential Product Interactions among Older Adults Living on the United States-Mexico Border , 2009, Drugs & aging.

[20]  P. Corey,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .

[21]  A. Jemal,et al.  Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[22]  L. Tanoue Cancer Statistics, 2009 , 2010 .

[23]  Atholl Johnston,et al.  Therapeutic drug monitoring of immunosuppressant drugs in clinical practice. , 2002, Clinical therapeutics.

[24]  Jennifer S. Haas,et al.  Trends in Prescription Drug Use Among Adults in the United States From 1999–2012 , 2016 .

[25]  G. Tognoni,et al.  Primary care as a permanent setting for researcha , 2012, Primary Health Care Research & Development.

[26]  P. Noyce,et al.  Hospital Admissions Associated with Adverse Drug Reactions: A Systematic Review of Prospective Observational Studies , 2008, The Annals of pharmacotherapy.

[27]  Josip Car,et al.  Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005 , 2007, BMC clinical pharmacology.

[28]  Andrew T Chan,et al.  Trends in Prescription Drug Use Among Adults in the United States From 1999-2012. , 2015, JAMA.

[29]  K. Alavi,et al.  Working with Existing Databases , 2013, Clinics in Colon and Rectal Surgery.

[30]  Catherine Yoon,et al.  The costs of adverse drug events in community hospitals. , 2012, Joint Commission journal on quality and patient safety.

[31]  D. Bates,et al.  The Costs of Adverse Drug Events in Hospitalized Patients , 1997 .

[32]  K. Fahrbach,et al.  Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. , 2004, Chest.

[33]  L. Thorndike Calculator , 1932, Speculum.

[34]  M. Cesari,et al.  Adverse Drug Reactions as Cause of Hospital Admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA) , 2002, Journal of the American Geriatrics Society.

[35]  D. Classen,et al.  Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. , 1997, JAMA.

[36]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[37]  Jürgen Stausberg,et al.  International prevalence of adverse drug events in hospitals: an analysis of routine data from England, Germany, and the USA , 2014, BMC Health Services Research.

[38]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[39]  F. Federico,et al.  Preventing medication errors. , 2000, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[40]  Miriam C.J.M. Sturkenboom,et al.  Adverse Drug Reaction-Related Hospitalisations , 2006, Drug safety.